Holen Sie sich die Stockscreener-App
29.23
0.31%
0.09
Schlusskurs vom Vortag:
$29.14
Offen:
$29.12
24-Stunden-Volumen:
221.41K
Relative Volume:
0.81
Marktkapitalisierung:
$595.34M
Einnahmen:
$982.01M
Nettoeinkommen (Verlust:
$14.80M
KGV:
79.00
EPS:
0.37
Netto-Cashflow:
$37.02M
1W Leistung:
-4.35%
1M Leistung:
+22.40%
6M Leistung:
+34.33%
1J Leistung:
+54.25%
1-Tages-Spanne:
$29.05
$29.66
1-Wochen-Bereich:
$28.75
$31.02
52-Wochen-Spanne:
$16.16
$31.80
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Vergleichen Sie PAHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
29.23 | 1.24B | 982.01M | 14.80M | 37.02M | 0.37 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Phibro Animal Health Corporation Stock Analysis and ForecastConsistent triple returns - PrintWeekIndia
Principal Financial Group Inc. Has $2.17 Million Holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World
What analysts say about Phibro Animal Health Corporation stockDouble-digit growth - jammulinksnews.com
Phibro Animal Health Corporation (NASDAQ:PAHC) Stock Holdings Trimmed by Teacher Retirement System of Texas - Defense World
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs - TradingView
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) - Yahoo Finance
Why Phibro Animal Health Corporation stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
How Phibro Animal Health Corporation stock performs during market volatilityFree Stock Index Interpretation - Newser
Best Growth Stocks to Buy for July 15th - The Globe and Mail
Here's Why Phibro Animal Health (PAHC) is a Strong Momentum Stock - Yahoo Finance
Phibro Animal Health (PAHC) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Phibro Animal Health stock reaches 52-week high at $30.60 By Investing.com - Investing.com South Africa
Phibro Animal Health stock reaches 52-week high at $30.60 - Investing.com India
Phibro (PAHC) Soars 6.8%: Is Further Upside Left in the Stock? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded by JPMorgan Chase & Co. to Overweight Rating - Defense World
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost - Benzinga
Phibro Animal Health (PAHC) Rises on J.P. Morgan Upgrade - GuruFocus
Phibro Animal Health shares surge on J.P. Morgan upgrade - grafa.com
Phibro Animal Health stock surges after JPMorgan upgrade to Overweight By Investing.com - Investing.com Nigeria
Phibro Animal Health stock surges after JPMorgan upgrade to Overweight - Investing.com Australia
Phibro rises after J.P. Morgan upgrades to 'overweight' - TradingView
U.S. Bancorp To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday - NewsBreak: Local News & Alerts
Phibro Animal Health (PAHC) Receives Upgrade and Price Target Bo - GuruFocus
This Constellation Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday - Benzinga
Phibro Animal Health upgraded to Overweight from Neutral at JPMorgan - TipRanks
Analog Devices, Constellation Brands, Phibro Animal Health - TradingView
JPMorgan upgrades Phibro Animal Health stock rating to Overweight on strong results - Investing.com
Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Phibro Animal Health stock hits 52-week high at 26.58 USD - Investing.com
Phibro Animal Health Corporation(NasdaqGM:PAHC) dropped from Russell 3000E Value Index - MarketScreener
Phibro Animal Health price target raised to $26 from $21 at Morgan Stanley - TipRanks
Best Growth Stocks to Buy for June 25th - yahoo.co
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Phibro Animal Health Corporation (NASDAQ:PAHC) Shares Sold by Rhumbline Advisers - Defense World
Reasons to Add PAHC Stock to Your Portfolio Right Now - Yahoo Finance
GAMMA Investing LLC Has $784,000 Stock Position in Phibro Animal Health Corporation (NASDAQ:PAHC) - Defense World
Phibro Animal Health (NASDAQ:PAHC) Upgraded to “Neutral” at BNP Paribas Exane - Defense World
Zacks.com featured highlights include Popular, Affiliated Managers, Astronics and Phibro Animal Health - The Globe and Mail
Phibro Animal Health upgraded to Neutral from Underperform at BNP Paribas Exane - TipRanks
Phibro Animal Health (PAHC) Rating Upgraded by Analyst | PAHC Stock News - GuruFocus
Phibro Animal Health (PAHC) Rating Upgraded by Analyst | PAHC St - GuruFocus
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Bank of America Corp DE Cuts Stake in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Zacks.com featured highlights Urban Outfitters, Phibro Animal Health and Strattec Security - Yahoo Finance
3 Stocks Showing Positive Momentum Despite Trade Tensions - Yahoo Finance
Cetera Investment Advisers Takes $204,000 Position in Phibro Animal Health Co. (NASDAQ:PAHC) - Defense World
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):